» Articles » PMID: 22411256

The Spinocerebellar Ataxias: Clinical Aspects and Molecular Genetics

Overview
Date 2012 Mar 14
PMID 22411256
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Spinocerebellar ataxias (SCAs) are a highly heterogeneous group of inherited neurological disorders, based on clinical characterization alone with variable degrees of cerebellar ataxia often accompanied by additional cerebellar and noncerebellar symptoms which in most cases defy differentiation. Molecular causative deficits in at least 31 genes underlie the clinical symptoms in the SCAs by triggering cerebellar and, very frequently, brain stem dysfunction. The identification of the causative molecular deficits enables the molecular diagnosis of the different SCA subtypes and facilitates genetic counselling. Recent scientific advances are shedding light into developing therapeutic strategies. The scope of this chapter is to provide updated details of the spinocerebellar ataxias with particular emphasis on those aspects aimed at facilitating the clinical and genetic diagnoses.

Citing Articles

Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases.

Scarabino D, Veneziano L, Fiore A, Nethisinghe S, Mantuano E, Garcia-Moreno H Antioxidants (Basel). 2022; 11(8).

PMID: 35892638 PMC: 9332235. DOI: 10.3390/antiox11081436.


Characterisation of canine KCNIP4: A novel gene for cerebellar ataxia identified by whole-genome sequencing two affected Norwegian Buhund dogs.

Jenkins C, Kalmar L, Matiasek K, Mari L, Kyostila K, Lohi H PLoS Genet. 2020; 16(1):e1008527.

PMID: 31999692 PMC: 7012447. DOI: 10.1371/journal.pgen.1008527.


Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.

Gomez-Ruiz M, Rodriguez-Cueto C, Luna-Pinel E, Hernandez-Galvez M, Fernandez-Ruiz J Front Mol Neurosci. 2019; 12:94.

PMID: 31068788 PMC: 6491810. DOI: 10.3389/fnmol.2019.00094.


SCA 6 with Writer's Cramp: The Phenotype Expanded.

Olszewska D, Walsh R, Lynch T Mov Disord Clin Pract. 2019; 3(1):83-86.

PMID: 30713900 PMC: 6353357. DOI: 10.1002/mdc3.12222.


Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.

Buijsen R, Toonen L, Gardiner S, van Roon-Mom W Neurotherapeutics. 2019; 16(2):263-286.

PMID: 30607747 PMC: 6554265. DOI: 10.1007/s13311-018-00696-y.